Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

OBJECTIVES: Drugs for Neglected Diseases initiative (DNDi) has identified three chemical lead series, the nitroimidazoles, benzoxaboroles and aminopyrazoles, as innovative treatments for visceral leishmaniasis. The leads discovered using phenotypic screening, were optimised following disease- and co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Parasitol Drugs Drug Resist
Main Authors: Van Bocxlaer, Katrien, Caridha, Diana, Black, Chad, Vesely, Brian, Leed, Susan, Sciotti, Richard J., Wijnant, Gert-Jan, Yardley, Vanessa, Braillard, Stéphanie, Mowbray, Charles E., Ioset, Jean-Robert, Croft, Simon L.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Includes articles from the special issue “Novel therapies for cutaneous leishmaniasis”, pp. 106 - 179
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6904836/
https://ncbi.nlm.nih.gov/pubmed/30922847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.02.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados